CCL2 and metabolic dysfunction-associated steatohepatitis: During HFHC-induced NASH, plasma MCP-1, and proinflammatory cytokines as well as expression of hepatic MCP-1 and fibrosis markers were markedly elevated to a greater extent in female than male mutants.